Animal Alternatives

Paris is not the genius behind this hysterical "beating of the bush," as others--notably the National Association for Biomedical Research--have been making a nice living with the same tactic for years. The simple fact is that most animal-rights activists embrace medical research, though not at the expense of sentient creatures. We are all concerned about our own health and the health of our loved ones; we decry the expenditure of b

Written byDonald Barnes
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Paris is not the genius behind this hysterical "beating of the bush," as others--notably the National Association for Biomedical Research--have been making a nice living with the same tactic for years.

The simple fact is that most animal-rights activists embrace medical research, though not at the expense of sentient creatures. We are all concerned about our own health and the health of our loved ones; we decry the expenditure of billions of tax dollars for treatment of diseases that could easily be prevented; and many of us support alternative methods of research with our own money.

For example, the National Anti-Vivisection Society, the charitable nonprofit organization for which I work, is the sole supporter of the International Foundation For EthicalResearch (IFER), which funds biomedical science directly in an attempt to find new techniques and methodologies which do not depend on animal suffering and death. Do we fit the mold into ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies